loadpatents
Patent applications and USPTO patent grants for Dodd; Aaron.The latest application filed is for "novel formulation of metaxalone".
Patent | Date |
---|---|
Method for improving the dissolution profile of a biologically active material App 20210401753 - Dodd; Aaron ;   et al. | 2021-12-30 |
Novel formulation of metaxalone App 20210403442 - DODD; Aaron ;   et al. | 2021-12-30 |
Production Of Encapsulated Nanoparticles At Commercial Scale App 20210260598 - Dodd; Aaron ;   et al. | 2021-08-26 |
Novel Formulation Of Meloxicam App 20210002267 - DODD; Aaron ;   et al. | 2021-01-07 |
Method for the Production of Commercial Nanoparticle and Microparticle Powders App 20200390710 - Dodd; Aaron ;   et al. | 2020-12-17 |
Method for improving the dissolution profile of a biologically active material App 20200375903 - Dodd; Aaron ;   et al. | 2020-12-03 |
Nanoparticle Compositions and Methods for Synthesis Thereof App 20200360294 - Payne; Trevor ;   et al. | 2020-11-19 |
Production of encapsulated nanoparticles at high volume fractions App 20200316546 - Dodd; Aaron ;   et al. | 2020-10-08 |
Novel formulation of metaxalone App 20200308123 - DODD; Aaron ;   et al. | 2020-10-01 |
Production Of Encapsulated Nanoparticles At Commercial Scale App 20190193085 - Dodd; Aaron ;   et al. | 2019-06-27 |
Formulation of indomethacin Grant 10,172,828 - Dodd , et al. J | 2019-01-08 |
Novel Formulation Of Diclofenac App 20180296514 - Dodd; Aaron ;   et al. | 2018-10-18 |
Novel formulation of metaxalone App 20180251433 - DODD; Aaron ;   et al. | 2018-09-06 |
Production of encapsulated nanoparticles at high volume fractions App 20180243707 - Dodd; Aaron ;   et al. | 2018-08-30 |
Novel Formulation Of Meloxicam App 20180194759 - DODD; Aaron ;   et al. | 2018-07-12 |
Production Of Encapsulated Nanoparticles At Commercial Scale App 20180169662 - Dodd; Aaron ;   et al. | 2018-06-21 |
Nanoparticle Composition and Methods for Synthesis Thereof App 20180169028 - Payne; Trevor ;   et al. | 2018-06-21 |
Method for improving the dissolution profile of a biologically active material App 20180169018 - Dodd; Aaron ;   et al. | 2018-06-21 |
Novel Formulation of Indomethacin App 20180117008 - Dodd; Aaron ;   et al. | 2018-05-03 |
Novel formulation of metaxalone App 20180009769 - DODD; Aaron ;   et al. | 2018-01-11 |
Formulation of indomethacin Grant 9,849,111 - Dodd , et al. December 26, 2 | 2017-12-26 |
Production of encapsulated nanoparticles at high volume fractions App 20170320030 - Dodd; Aaron ;   et al. | 2017-11-09 |
Method for the Production of Commercial Nanoparticle and Microparticle Powders App 20170165203 - Dodd; Aaron ;   et al. | 2017-06-15 |
Novel Formulation Of Diclofenac App 20170100356 - Dodd; Aaron ;   et al. | 2017-04-13 |
Novel Formulation of Indomethacin App 20170095448 - Dodd; Aaron ;   et al. | 2017-04-06 |
Formulation of indomethacin Grant 9,522,135 - Dodd , et al. December 20, 2 | 2016-12-20 |
Novel Formulation of Naproxen App 20160220518 - Dodd; Aaron ;   et al. | 2016-08-04 |
Novel formulation of metaxalone App 20160108009 - DODD; Aaron ;   et al. | 2016-04-21 |
Novel Formulation Of Meloxicam App 20160102086 - DODD; Aaron ;   et al. | 2016-04-14 |
Novel Formulation Of Diclofenac App 20160067199 - DODD; Aaron ;   et al. | 2016-03-10 |
Novel Formulation Of Diclofenac App 20160058707 - DODD; Aaron ;   et al. | 2016-03-03 |
Novel Formulation of Indomethacin App 20160022637 - Dodd; Aaron ;   et al. | 2016-01-28 |
Formulation of diclofenac Grant 9,186,328 - Dodd , et al. November 17, 2 | 2015-11-17 |
Formulation of diclofenac Grant 9,180,096 - Dodd , et al. November 10, 2 | 2015-11-10 |
Formulation of diclofenac Grant 9,180,095 - Dodd , et al. November 10, 2 | 2015-11-10 |
Novel Formulation of Naproxen App 20150313857 - Dodd; Aaron ;   et al. | 2015-11-05 |
Formulation of diclofenac Grant 9,173,854 - Dodd , et al. November 3, 2 | 2015-11-03 |
Production of encapsulated nanoparticles at high volume fractions App 20150306556 - Dodd; Aaron ;   et al. | 2015-10-29 |
Formulation of indomethacin Grant 9,095,496 - Dodd , et al. August 4, 2 | 2015-08-04 |
Production Of Encapsulated Nanoparticles At Commercial Scale App 20150209796 - DODD; Aaron ;   et al. | 2015-07-30 |
Formulation of indomethacin Grant 9,089,471 - Dodd , et al. July 28, 2 | 2015-07-28 |
Novel Formulation Of Diclofenac App 20150157573 - DODD; Aaron ;   et al. | 2015-06-11 |
Novel Formulation Of Diclofenac App 20150150805 - DODD; Aaron ;   et al. | 2015-06-04 |
Novel Formulation Of Diclofenac App 20150150823 - DODD; Aaron ;   et al. | 2015-06-04 |
Novel Formulation Of Diclofenac App 20150150824 - DODD; Aaron ;   et al. | 2015-06-04 |
Formulation of diclofenac Grant 9,017,721 - Dodd , et al. April 28, 2 | 2015-04-28 |
Formulation of diclofenac Grant 8,999,387 - Dodd , et al. April 7, 2 | 2015-04-07 |
Formulation of indomethacin Grant 8,992,982 - Dodd , et al. March 31, 2 | 2015-03-31 |
Novel Formulation of Naproxen App 20150087709 - Dodd; Aaron ;   et al. | 2015-03-26 |
Method for the Production of Commercial Nanoparticle and Microparticle Powders App 20140326812 - DODD; Aaron ;   et al. | 2014-11-06 |
Novel formulation of metaxalone App 20140302127 - DODD; Aaron ;   et al. | 2014-10-09 |
Novel Formulation of Indomethacin App 20140255494 - Dodd; Aaron ;   et al. | 2014-09-11 |
Novel Formulation of Indomethacin App 20140256781 - Dodd; Aaron ;   et al. | 2014-09-11 |
Novel Formulation Of Diclofenac App 20140248359 - DODD; Aaron ;   et al. | 2014-09-04 |
Novel Formulation Of Diclofenac App 20140220121 - DODD; Aaron ;   et al. | 2014-08-07 |
Novel Formulation Of Naproxen App 20140200276 - DODD; Aaron ;   et al. | 2014-07-17 |
Novel Formulation Of Meloxicam App 20140199395 - DODD; Aaron ;   et al. | 2014-07-17 |
Novel Formulation of Indomethacin App 20140194487 - Dodd; Aaron ;   et al. | 2014-07-10 |
Formulation of diclofenac Grant 8,735,450 - Dodd , et al. May 27, 2 | 2014-05-27 |
Formulation of indomethacin Grant 8,734,847 - Dodd , et al. May 27, 2 | 2014-05-27 |
Formulation of diclofenac Grant 8,679,544 - Dodd , et al. March 25, 2 | 2014-03-25 |
Method for improving the dissolution profile of a biologically active material App 20130277468 - Dodd; Aaron ;   et al. | 2013-10-24 |
Novel Formulation Of Indomethacin App 20130243854 - Dodd; Aaron ;   et al. | 2013-09-19 |
Novel Formulation Of Diclofenac App 20130209569 - Dodd; Aaron ;   et al. | 2013-08-15 |
Novel Formulation Of Metaxalone App 20120263760 - Dodd; Aaron ;   et al. | 2012-10-18 |
Production Of Encapsulated Nanoparticles At Commercial Scale App 20120202694 - Dodd; Aaron ;   et al. | 2012-08-09 |
Method For The Production Of Commercial Nanoparticle And Micro Particle Powders App 20120160944 - Dodd; Aaron ;   et al. | 2012-06-28 |
Method For Improving The Dissolution Profile Of A Biologically Active Material App 20120165323 - Dodd; Aaron ;   et al. | 2012-06-28 |
Production Of Encapsulated Nanoparticles At High Volume Fractions App 20120165410 - Dodd; Aaron ;   et al. | 2012-06-28 |
Novel Formulation Of Naproxen App 20120148634 - Dodd; Aaron ;   et al. | 2012-06-14 |
Novel Formulation Of Meloxicam App 20120141548 - Dodd; Aaron ;   et al. | 2012-06-07 |
Novel Formulation Of Diclofenac App 20120135047 - Dodd; Aaron ;   et al. | 2012-05-31 |
Novel Formulation Of Indomethacin App 20120135048 - Dodd; Aaron ;   et al. | 2012-05-31 |
Nanoparticle Composition And Methods Of Synthesis Thereof App 20090028948 - Payne; Trevor ;   et al. | 2009-01-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.